Compound Radar

Bausch + Lomb Corporation (BLCO) Stock Analysis

Price $20.00
Market cap $7.15B
Entry status Wait

Last updated Oct 30, 2026

Health Check

Last analyzed Oct 30, 2026

28
28/100 Avoid
  • Financial Health 20
  • Profitability 50
  • Business Quality 75
  • Balance Sheet 30
  • Cash Flow 25

Why this rating?

Health 28/100 — Avoid

Strongest Business Quality 75/100
Softest Financial Health 20/100
Wait

Entry timing is weak right now. Quality may be fine; the setup is not.

Company overview

Bausch + Lomb Corporation (BLCO) is a Medical Instruments & Supplies company in the Healthcare sector. Compound Radar rates Bausch + Lomb Corporation 28/100 (Avoid) due to high business quality, steady revenue growth, and elevated leverage.

Investment profile

  • Quality High
  • Growth Moderate
  • Balance Sheet Stretched
  • Valuation Attractive

Financial highlights

Valuation

  • Forward P/E 16.75
  • PEG 0.89

Profitability

  • Revenue Growth 7.3%
  • Gross Margin 62.6%
  • Operating Margin 11.3%
  • Net Margin -2.0%

Financial strength

  • Free Cash Flow $-66.00M

Similar companies

Peers in Medical Instruments & Supplies, ranked by Financial Health.

Company Ticker
Price Current price

Latest quoted price for the name. Helps anchor the setup in today’s market level.

Health Entry

View all in Medical Instruments & Supplies →

FAQ

How Compound Radar scores and tracks Bausch + Lomb Corporation (BLCO).

View Methodology & FAQ →